Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial

Myhre, PL; Kalstad, AA; Tveit, SH; Laake, K; Schmidt, EB; Smith, P; Nilsen, DWT; Tveit, A; Solheim, S; Arnesen, H; Seljeflot, I

Myhre, PL (通讯作者),Akershus Univ Hosp, Div Med, Dept Cardiol, Sykehusveien 27, N-1478 Lorenskog, Norway.

JOURNAL OF INTERNAL MEDICINE, 2022; 291 (5): 637

Abstract

Background The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myocardial infarction (AMI) is controversial, and the i......

Full Text Link